The development and implementation of a TMT-SRM assay for the validation of candidate biomarkers of Alzheimer's disease

Biomarker discovery studies in plasma have revealed several proteins which may have clinical utility in the diagnosis and prognosis of Alzheimer’s disease. The qualification of these proteins as true biomarkers, sensitive and specific to the disease, requires rapid, high quality, quantitative assays...

Full description

Bibliographic Details
Main Author: O'Brien, Darragh
Published: King's College London (University of London) 2011
Subjects:
Online Access:http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.628031